COVID hospitalization much more likely for the unvaccinated in nation’s second largest metropolis

Data from the CDC’s Aug. 24 Morbidity and Mortality Weekly Report (MMWR) shows fully vaccinated persons aged 16 years or older with COVID-19 were less likely than unvaccinated residents to be hospitalized, admitted to an intensive care unit, require mechanical ventilation or die from COVID when the Delta variant began emerging.

Researchers analyzed the cases of 43,127 Los Angeles County residents who had COVID-19 between May 1 and July 25 of this year. Twenty-five percent were fully vaccinated, 3% were partially vaccinated and 71% were unvaccinated.  

According to the report, infection and hospitalization rates among unvaccinated persons were 4.9 and 29.2 times the rates, respectively, compared with fully vaccinated individuals.

“These data indicate that authorized vaccines protect against SARS-CoV-2 infection and severe COVID-19, even with increased community transmission of the newly predominant Delta variant. Efforts to enhance COVID-19 vaccination coverage, in coordination with other prevention strategies, are critical to preventing COVID-19–related hospitalizations and deaths,” the CDC said.

Read the full report here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.